1. Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy 
Ulrich R. Müller, MD, Marek Jutel, MD, Andrea Reimers, MD, Judith Zumkehr, Sci Tec, Clarissa Huber, MD, Carola Kriegel, MD, Urs Steiner, MD, Gabrielle Haeberli, MD, Mübeccel Akdis, MD, PhD, Arthur Helbling, MD, Benno Schnyder, MD, Kurt Blaser, PhD, Cezmi Akdis, MD 
Journal of Allergy and Clinical Immunology 
Volume 122, Issue 5, Pages e4 (November 2008)
DOI: /j.jaci
Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
BV sIgE and sIgG antibodies and PLA-stimulated proliferation of PBMCs during ultrarush BVIT. A, sIgE levels did not change significantly, although there was a highly significant increase of sIgG levels in both groups. B, PLA-stimulated proliferation decreased in both groups, but the reduction reached significance only in the LC group on day 110. P, Placebo.
Journal of Allergy and Clinical Immunology  , e4DOI: ( /j.jaci )
Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Fig 2
Cytokine secretion in PLA-stimulated PBMC cultures during BVIT. A, IFN-γ levels decreased significantly more in the placebo group on day 21. B, IL-13 levels decreased in both groups between before BVIT and day 110 but significantly more in the placebo group. C, IL-10 levels increased significantly on day 21 compared with those before BVIT in the LC group. P, Placebo.
Journal of Allergy and Clinical Immunology  , e4DOI: ( /j.jaci )
Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4. Fig 3
Effect of BVIT on HR expression in PLA-stimulated T cells. A, HR1 mRNA expression. B, HR2 mRNA expression. C, HR1/HR2 mRNA expression ratio. Although no significant difference in HR1 and HR2 expression is observed between groups, the HR1/HR2 ratio is significantly lower in the placebo group on day 21. P, Placebo.
Journal of Allergy and Clinical Immunology  , e4DOI: ( /j.jaci )
Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions